nizatidine has been researched along with Gastritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futagami, S; Gudis, K; Hiratsuka, T; Iwakiri, K; Miyake, K; Nishigaki, H; Sakamoto, C; Shinji, Y; Shinoki, K; Tsukui, T; Wada, K; Yamada, N | 1 |
| Cloud, ML; Offen, W | 1 |
2 trial(s) available for nizatidine and Gastritis
| Article | Year |
|---|---|
Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
Topics: Anti-Ulcer Agents; Biopsy; Cell Line; Diterpenes; Epithelial Cells; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Interleukin-8; Male; Middle Aged; Neutrophil Infiltration; Nizatidine; Pepsinogen A; Pepsinogen C; Sucralfate; Urease | 2004 |
Continuous infusions of nizatidine are safe and effective in the treatment of intensive care unit patients at risk for stress gastritis. The Nizatidine Intensive Care Unit Study Group.
Topics: Adult; Analysis of Variance; Critical Care; Double-Blind Method; Female; Gastric Acid; Gastritis; Gastrointestinal Hemorrhage; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Nizatidine; Stress, Physiological | 1994 |